Edition:
India

BioScrip Inc (BIOS.OQ)

BIOS.OQ on NASDAQ Stock Exchange Global Select Market

2.48USD
22 Nov 2017
Change (% chg)

$-0.03 (-1.20%)
Prev Close
$2.51
Open
$2.52
Day's High
$2.63
Day's Low
$2.45
Volume
528,660
Avg. Vol
324,261
52-wk High
$3.39
52-wk Low
$0.98

Latest Key Developments (Source: Significant Developments)

Bioscrip reports qtrly ‍loss per share $0.12​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Bioscrip Inc :Bioscrip reports third quarter 2017 financial results.Q3 revenue $198.7 million versus I/B/E/S view $200.9 million.Sees FY 2017 revenue $805 million to $810 million.Bioscrip Inc says ‍updated its adjusted EBITDA guidance to a range of $42.0 million to $44.0 million for full-year 2017​.Bioscrip Inc - Qtrly ‍loss per share $0.12​.Bioscrip Inc sees FY 2017 ‍loss per share in range of $0.58 to $0.64.FY2017 earnings per share view $-0.55, revenue view $824.5 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article

Bioscrip files for offering of up to 3.75 mln shares of common stock by the selling stockholder
Tuesday, 11 Oct 2016 

Bioscrip Inc :Files for offering of up to 3.75 million shares of common stock by the selling stockholder - sec filing.  Full Article

Bioscrip And Home Solutions enter deal to expedite closing
Saturday, 3 Sep 2016 

Press Release : Bioscrip and home solutions enter into amended asset purchase agreement to expedite closing . Co, hs infusion holdings inc further amended terms of their asset purchase agreement dated june 13, 2016 .Amended agreement to eliminate condition to closing that co receive stockholder approval to increase authorized share capital.  Full Article

Bioscrip enters into a tax asset protection plan
Friday, 12 Aug 2016 

Bioscrip Inc : Tax asset protection plan to protect company's ability to "utilize its net operating loss carryforwards" which total approximately $275 million . Bioscrip enters into a tax asset protection plan to protect its valuable tax assets . Will distribute to stockholders non-taxable dividend distribution of 1 preferred stock purchase right for each share of common stock of Co .Tax asset protection plan intended to act as "deterrent" to any person acquiring beneficial ownership of 4.9% or more of Co's common stock.  Full Article

North Tide Capital Master reports a passive stake of 7.5 pct in Bioscrip Inc
Tuesday, 28 Jun 2016 

Bioscrip Inc :North Tide Capital Master LP reports a passive stake of 7.5 percent in Bioscrip Inc as of June 17, 2016 - SEC filing.  Full Article

BioScrip prices 40 mln shares offering at $2.00 per share
Friday, 17 Jun 2016 

BioScrip Inc : Says offering of 40.0 million common shares priced at $2.00 per share . Says expects to receive approximately $73.38 million in net proceeds from offering after deducting underwriting discounts .BioScrip prices underwritten offering of common stock.  Full Article

BioScrip to acquire Home Solutions
Monday, 13 Jun 2016 

BioScrip Inc : Total transaction consideration of $85.0 million . Will acquire substantially all of assets and assume certain liabilities of Home Solutions and its subsidiaries . Deal includes additional contingent consideration in form of restricted stock units . Closing consideration will consist of $80.0 million payable in cash, subject to certain adjustments and $5.0 million in shares . BioScrip inc says upon completion of transaction, Daniel Greenleaf will become chief executive officer of BioScrip . Upon completion of transaction, Daniel Greenleaf will become chief executive officer of BioScrip and join company's board . Rick Smith, director and chief executive officer of BioScrip will become vice chairman of board of directors . Jeffrey Kreger, chief financial officer of BioScrip, will serve as combined company's chief financial officer . BioScrip will continue to be headquartered in Denver, Colorado and plans to maintain branches throughout United States . Transaction is anticipated to be financed through net proceeds from an equity offering . Jefferies LLC is acting as financial advisor to BioScrip . Houlihan Lokey is acting as financial advisor to Home Solutions .BioScrip announces transformative acquisition of Home Solutions that will enhance focus as home infusion leader.  Full Article

Bioscrip announces proposed public offering of common stock
Monday, 13 Jun 2016 

Bioscrip Inc : Commenced an underwritten public offering of its common stock .Bioscrip announces proposed public offering of common stock.  Full Article

BRIEF-BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis

* BioScrip says can now dispense & administer Radicava (edaravone) treatment option for amyotrophic lateral sclerosis approved by U.S. FDA Source text for Eikon: Further company coverage: